Table_1_Plasma Circular RNAs hsa_circ_0001953 and hsa_circ_0009024 as Diagnostic Biomarkers for Active Tuberculosis.doc
Recent studies have demonstrated that circular RNAs (circRNAs) could serve as potential molecular markers for disease diagnosis; however, little is known about their diagnostic value in active tuberculosis (TB). This study first performed a microarray screening of circRNA changes in plasma samples from 3 patients with active pulmonary TB and 3 healthy controls. Then, candidate circRNAs were selected for validation on a quantitative real-time PCR system. Of the 61 differentially expressed circRNAs recorded, 43 and 18 were upregulated and downregulated in the TB group, respectively. Validation assays demonstrated that plasma levels of 6 circRNAs, including hsa_circ_0009024, hsa_circ_0001953, hsa_circ_0008297, hsa_circ_0003528, hsa_circ_0003524 and hsa_circ_0015879 were remarkably increased in TB patients. Plasma levels of hsa_circ_0001953 and hsa_circ_0009024 were correlated with TB severity. Next, hsa_circ_0001953 and hsa_circ_0009024 were assessed in an independent cohort consisting of 120 TB patients and 100 control individuals. An area under the receiver operating characteristic (ROC) curve of 0.915 (95% confidence interval 0.880-0.951; P < 0.001) was obtained for detecting TB, with hsa_circ_0001953 and hsa_circ_0009024 used in combination. Additionally, plasma levels of hsa_circ_0001953 and hsa_circ_0009024 were reduced significantly in patients after treatment (P < 0.001). The present findings indicate that the circRNAs hsa_circ_0001953 and hsa_circ_0009024 may represent novel plasma biomarkers for active TB diagnosis.
History
References
- https://doi.org//10.1007/s10753-014-9978-y
- https://doi.org//10.1016/j.meegid.2016.09.023
- https://doi.org//10.1183/13993003.00543-2016
- https://doi.org//10.1016/j.tube.2015.12.004
- https://doi.org//10.1136/jmedgenet-2016-103758
- https://doi.org//10.1016/S0140-6736(15)00151-8
- https://doi.org//10.1080/15476286.2016.1271524
- https://doi.org//10.1155/2017/5135781
- https://doi.org//10.1128/JCM.05459-11
- https://doi.org//10.1038/srep20703
- https://doi.org//10.3389/fmolb.2017.00038
- https://doi.org//10.1016/j.canlet.2017.03.027
- https://doi.org//10.1038/s41598-017-13885-0
- https://doi.org//10.1159/000487454
- https://doi.org//10.1016/j.tube.2015.03.006
- https://doi.org//10.1016/S0140-6736(16)00710-8
- https://doi.org//10.1016/j.jbiotec.2016.09.011
- https://doi.org//10.1183/09031936.00221514
- https://doi.org//10.1016/j.cca.2018.01.026
- https://doi.org//10.1007/s00109-017-1600-y
- https://doi.org//10.1186/s12943-017-0630-y
- https://doi.org//10.3389/fgene.2013.00307
- https://doi.org//10.1371/journal.pone.0141214
- https://doi.org//10.1371/journal.pone.0080149
- https://doi.org//10.1038/s41598-017-12550-w
- https://doi.org//10.4049/jimmunol.1400124
- https://doi.org//10.1016/j.ebiom.2017.12.007
- https://doi.org//10.1073/pnas.1112660108
- https://doi.org//10.18632/oncotarget.19154
- https://doi.org//10.3389/fmicb.2018.00602
- https://doi.org//10.1038/srep40342
- https://doi.org//10.1371/journal.ppat.1003697
- https://doi.org//10.1016/j.febslet.2012.06.004
- https://doi.org//10.1016/j.cca.2017.10.011.
- https://doi.org//10.1371/journal.pone.0081076
- https://doi.org//10.1159/000489657
- https://doi.org//10.1038/srep39918
- https://doi.org//10.1016/j.molimm.2017.08.008
CC BY 4.0